206 related articles for article (PubMed ID: 32663668)
41. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Zurenko GE; Yagi BH; Schaadt RD; Allison JW; Kilburn JO; Glickman SE; Hutchinson DK; Barbachyn MR; Brickner SJ
Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
[TBL] [Abstract][Full Text] [Related]
42. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
[TBL] [Abstract][Full Text] [Related]
43. New Unnatural Gallotannins: A Way toward Green Antioxidants, Antimicrobials and Antibiofilm Agents.
Hricovíniová Z; Mascaretti Š; Hricovíniová J; Čížek A; Jampílek J
Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439536
[TBL] [Abstract][Full Text] [Related]
44. Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts.
Cetinkaya E; Denizci A; Ozdemir I; Oztürk HT; Karaboz I; Cetinkaya B
J Chemother; 2002 Jun; 14(3):241-5. PubMed ID: 12120877
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
46. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
47. Piperazine derivatives of benzimidazole as potential anthelmintics. Part 1: Synthesis and activity of methyl-5-(4-substituted piperazin-1-yl)benzimidazole-2-carbamates.
Sánchez-Alonso RM; Raviña E; Santana L; García-Mera G; Sanmartín M; Baltar P
Pharmazie; 1989 Sep; 44(9):606-7. PubMed ID: 2608706
[TBL] [Abstract][Full Text] [Related]
48. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
Dowzicky M; Nadler HL; Feger C; Talbot G; Bompart F; Pease M
Am J Med; 1998 May; 104(5A):34S-42S. PubMed ID: 9684656
[TBL] [Abstract][Full Text] [Related]
50. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
51. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
52. Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial Drugs.
Kucerova-Chlupacova M; Vyskovska-Tyllova V; Richterova-Finkova L; Kunes J; Buchta V; Vejsova M; Paterova P; Semelkova L; Jandourek O; Opletalova V
Molecules; 2016 Oct; 21(11):. PubMed ID: 27801810
[TBL] [Abstract][Full Text] [Related]
53. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and antibacterial evaluation of certain quinolone derivatives.
Chen YL; Fang KC; Sheu JY; Hsu SL; Tzeng CC
J Med Chem; 2001 Jul; 44(14):2374-7. PubMed ID: 11428933
[TBL] [Abstract][Full Text] [Related]
55. Consensus-Based Pharmacophore Mapping for New Set of
Bak A; Kos J; Michnova H; Gonec T; Pospisilova S; Kozik V; Cizek A; Smolinski A; Jampilek J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916824
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Fukai T; Oku Y; Hano Y; Terada S
Planta Med; 2004 Jul; 70(7):685-7. PubMed ID: 15303263
[TBL] [Abstract][Full Text] [Related]
58. A newly isolated Streptomyces sp. CS392 producing three antimicrobial compounds.
Cho SS; Choi YH; Simkhada JR; Mander P; Park DJ; Yoo JC
Bioprocess Biosyst Eng; 2012 Jan; 35(1-2):247-54. PubMed ID: 21909674
[TBL] [Abstract][Full Text] [Related]
59. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.
Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Zweifel MJ; Wilkie SC; Rodriguez MJ; Thompson RC; Cooper RD
Antimicrob Agents Chemother; 1996 Sep; 40(9):2194-9. PubMed ID: 8878606
[TBL] [Abstract][Full Text] [Related]
60. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
